# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-022126
Filing Date
2019-04-30
Accepted
2019-04-30 08:30:46
Documents
6
Period of Report
2019-06-11
Effectiveness Date
2019-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | tv519344-def14a.htm | DEF 14A | 532593
2 | GRAPHIC | lg_eyenovia.jpg | GRAPHIC | 79849
3 | GRAPHIC | ico_member.jpg | GRAPHIC | 13246
4 | GRAPHIC | ico_chair.jpg | GRAPHIC | 15818
5 | GRAPHIC | tv519344_pc1.jpg | GRAPHIC | 453310
6 | GRAPHIC | tv519344_pc2.jpg | GRAPHIC | 284399
| Complete submission text file | 0001144204-19-022126.txt |  | 1667102

Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38365 | Film No.: 19778634
SIC: 2834 Pharmaceutical Preparations